← Leaderboards
Rup Tandan
University Of Vermont &St Agric College
$468,554
Attributed
$468,554
Total exposure
29
Grants
22
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $119.1K · FY2005–10$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$468,554 · 29
By mechanism
M01$468,554 · 29
Top collaborators
No co-investigators on record.
Most similar at University Of Vermont &St Agric College
Same institution · by research overlap
- Michael J Toth$13,490,593
- Dwight E. Matthews$4,596,582
- Naomi K Fukagawa$3,762,860
- Thomas Lahiri$89,769
Others in their field
Top investigators on “Amyotrophic Lateral Sclerosis”
- Merit E Cudkowicz · Massachusetts General Hospital$54,029,758
- James Dale Berry · Brigham And Women'S Hospital$37,291,450
- Sabrina Paganoni · Massachusetts General Hospital$36,168,406
- Suma Babu · Massachusetts General Hospital$36,168,406
- Jeffrey D Rothstein · Massachusetts General Hospital$22,909,620
- Teepu Siddique · University Of Chicago$22,641,778
Research focus
Amyotrophic Lateral SclerosisResourcesSourceUnited States National Institutes Of HealthGrantResearch PersonnelComputer Retrieval Of Information On Scientific Projects DatabaseFundingInstitutionClinical TrialsClinical ResearchHuman SubjectSafetyNeuromuscular Disorder ChemotherapyHuman Therapy EvaluationDrug Screening /EvaluationRandomizedUpper ArmPoliomyelitisNeuroprotectantsBlindAdverse EventBioenergeticsMotor Neurons
Grant awards (38)
CLINICAL TRIAL: THYMECTOMY IN NON-THYMOMATOUS MG PTS RECEIVING PREDINISONE$1,712
M01 · FY2010 · RR · contact PI
CLINICAL TRIAL: PILOT TRIAL OF RITUXIMAB IN REFRACTORY MYASTHENIA GRAVIS$13,988
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: EARLY TREATMENT OF ALS WITH NUTRITION AND NIPPV$6,527
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: THYMECTOMY IN NON-THYMOMATOUS MG PTS RECEIVING PREDINISONE$3,729
M01 · FY2009 · RR · contact PI
RADIOLOGICAL CORRELATES OF COGNITIVE DYSFUNCTION IN ALS$1,866
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: EARLY TREATMENT OF ALS WITH NUTRITION AND NIPPV$50,956
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: CLINICAL TRIAL OF HIGH DOSE COQ10 IN ALS$38,217
M01 · FY2008 · RR · contact PI
RADIOLOGICAL CORRELATES OF COGNITIVE DYSFUNCTION IN ALS$11,989
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: PILOT TRIAL OF RITUXIMAB IN REFRACTORY MYASTHENIA GRAVIS$8,244
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: EFFECT OF THYMECTOMY IN NON-THYMOMATOUS MG PATIENTS ON PREDNISON$5,245
M01 · FY2008 · RR · contact PI
MEASURING QUALITY OF LIFE IN INDIVIDUALS WITH AMYOTROPHIC LATERAL SCLEROSIS$4,496
M01 · FY2008 · RR · contact PI
EARLY TREATMENT OF ALS WITH NUTRITION AND NIPPV$51,897
M01 · FY2007 · RR · contact PI
PILOT TRIAL OF RITUXIMAB IN REFRACTORY MYASTHENIA GRAVIS$14,500
M01 · FY2007 · RR · contact PI
COMBINATION DRUG TRIAL IN AMYOTROPHIC LATERAL SCLEROSIS$14,500
M01 · FY2007 · RR · contact PI
TRIAL OF MINOCYCLINE IN 400 SUBJECTS WITH ALS$12,975
M01 · FY2007 · RR · contact PI
CLINICAL TRIAL OF HIGH DOSE COQ10 IN ALS$6,869
M01 · FY2007 · RR · contact PI
ALS RESEARCH GROUP DNA BANKING STUDY$6,106
M01 · FY2007 · RR · contact PI
EFFECT OF THYMECTOMY IN NON-THYMOMATOUS MG PATIENTS ON PREDNISONE$762
M01 · FY2007 · RR · contact PI
TRIAL OF MINOCYCLINE IN 400 SUBJECTS WITH ALS$43,621
M01 · FY2006 · RR · contact PI
CLINICAL TRIAL OF HIGH DOSE COQ10 IN ALS$6,384
M01 · FY2006 · RR · contact PI
THE ASSESSMENT OF CALORIC NEEDS IN AMYOTROPHIC LATERAL SCLEROSIS$6,384
M01 · FY2006 · RR · contact PI
EARLY TREATMENT OF ALS WITH NUTRITION AND NIPPV$5,319
M01 · FY2006 · RR · contact PI
TRIAL OF MINOCYCLINE IN 400 SUBJECTS WITH ALS$34,653
M01 · FY2005 · RR
PILOT TRIAL OF RITUXIMAB IN REFRACTORY MYASTHENIA GRAVIS$15,709
M01 · FY2005 · RR
CLINICAL TRIAL OF CELEBREX IN SUBJECTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS)$9,241
M01 · FY2005 · RR
THE ASSESSMENT OF CALORIC NEEDS IN AMYOTROPHIC LATERAL SCLEROSIS$6,469
M01 · FY2005 · RR
Clinical Trial of Celebrex in Subjects with Amyotrophic Lateral Sclerosis (ALS)$53,781
M01 · FY2004 · RR
The Assessment of Caloric Needs in Amyotrophic Lateral Sclerosis$31,679
M01 · FY2004 · RR
Clinical Trial of Creatine in Amyotrophic Lateral Sclero$736
M01 · FY2004 · RR
ENERGY METABOLISM IN AMYOTROPHIC LATERAL SCLEROSIS$0
M01 · FY2002 · RR
TRIAL OF TOPIRAMATE IN AMYOTROPHIC LATERAL SCLEROSIS$0
M01 · FY2002 · RR
A TRIAL OF MESTINON IN POST POLIOMYELITIS SYNDROME$0
M01 · FY2002 · RR
A TRIAL OF MESTINON IN POST POLIOMYELITIS SYNDROME$0
M01 · FY2000 · RR
TRIAL OF TOPIRAMATE IN AMYOTROPHIC LATERAL SCLEROSIS$0
M01 · FY2000 · RR
TRIAL OF TOPIRAMATE IN AMYOTROPHIC LATERAL SCLEROSIS$0
M01 · FY2000 · RR
ENERGY METABOLISM IN AMYOTROPHIC LATERAL SCLEROSIS$0
M01 · FY2000 · RR
ENERGY METABOLISM IN AMYOTROPHIC LATERAL SCLEROSIS$0
M01 · FY2000 · RR
A TRIAL OF MESTINON IN POST POLIOMYELITIS SYNDROME$0
M01 · FY2000 · RR